Professional development participation is not associated with a decrease in total publication. حسب Patrick D. Brandt (4449211)

RAC1 inhibition results in a decrease in oxidative phosphorylation. حسب Shruthi Sriramkumar (12705564)

Effect of 5-HT depletion via pCPA on incentive. حسب Yukiko Hori (299784)

الموضوعات:

Antagonist dosage and occupancy for each 5-HT receptor subtype. حسب Yukiko Hori (299784)

الموضوعات:

Quercetin decreased mitochondrial- and intercellular ROS. حسب Takaya Sugawara (9338487)

Lymphocytes decreased in mouse pneumonia model. حسب Qi Xu (134661)

Ellagic acid decreases mitochondrial damages. حسب Ahmad Salimi (10204515)

Probability of release is decreased by hydrophobic mutations. حسب Matthew R. Bowers (8423115)

Effect of the temperature and protease inhibition on the <i>A</i>. <i>simplex</i>-induced TEER decrease. حسب Noelia Carballeda-Sangiao (2889611)

N-acetilcysteine prevents the <i>A</i>. <i>simplex</i> CE-induced TEER decrease. حسب Noelia Carballeda-Sangiao (2889611)

The influence of 5-HT supplement on mosquito feeding capacity. حسب Li Gao (131516)

Effect of IDO on brain 5-HT level. حسب Masatoshi Ohnishi (14587632)

Loss of Prox1a decreases PR production at 120 hours post-ablation. حسب Kellie Veen (17343374)

Mitochondrial protein acetylation correlates with a decrease in sirtuin 3 levels. حسب Mercedes García-Roche (6459200)

Image 1_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.pdf حسب Francesca Bietto (21511316)

"…</p>Methods<p>This study aimed to develop an in vitro model of the infant gut barrier treating Caco-2/HT29-MTX with 0.5, 0.8, and 1 mM sodium glycodeoxycholate (GDC).…"

Table 1_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.docx حسب Francesca Bietto (21511316)

"…</p>Methods<p>This study aimed to develop an in vitro model of the infant gut barrier treating Caco-2/HT29-MTX with 0.5, 0.8, and 1 mM sodium glycodeoxycholate (GDC).…"

Image 4_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.pdf حسب Francesca Bietto (21511316)

"…</p>Methods<p>This study aimed to develop an in vitro model of the infant gut barrier treating Caco-2/HT29-MTX with 0.5, 0.8, and 1 mM sodium glycodeoxycholate (GDC).…"

Image 2_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.pdf حسب Francesca Bietto (21511316)

"…</p>Methods<p>This study aimed to develop an in vitro model of the infant gut barrier treating Caco-2/HT29-MTX with 0.5, 0.8, and 1 mM sodium glycodeoxycholate (GDC).…"

Image 3_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.pdf حسب Francesca Bietto (21511316)

"…</p>Methods<p>This study aimed to develop an in vitro model of the infant gut barrier treating Caco-2/HT29-MTX with 0.5, 0.8, and 1 mM sodium glycodeoxycholate (GDC).…"

OPG147 has no effect on TBK1 or IRF3-mediated ISRE activation and HT-DNA-induced signaling. حسب Xue-Mei Yi (18851202)